Related Stories
Progress
For Sopharma AD this effort is another contribution to an excellent corporate governance file.
Financial structure | ||||
---|---|---|---|---|
BGN '000 | 31.12.2019 | 31.12.2018 | 31.12.2017 | 31.12.2016 |
Medium and long-term debt | 82,672 | 43,610 | 52,476 | 28,506 |
Short-term debt | 268,111 | 282,173 | 229,317 | 201,457 |
Cash and cash equivalents | 27,362 | 25,582 | 22,614 | 22,339 |
Net debt | 386,670 | 300,201 | 259,179 | 207,624 |
Equity attributable to equity holders of the parent | 556,431 | 475,560 | 469,883 | 457,490 |
Non-controlling interest | 19,341 | 32,639 | 33,227 | 33,733 |
Total equity | 575,772 | 508,529 | 503,110 | 491,223 |
Net debt/Total equity | 0.67 | 0.59 | 0.52 | 0.42 |
Net debt/EBITDA | 3.68 | 4.15 | 3.01 | 2.82 |